Sermorelin 3mg/mL (5mL)
- A sermorelin peptide treatment option available through provider-guided care.
- Treatment requires review by a licensed healthcare provider and a prescription when clinically appropriate.
Sermorelin is a synthetic peptide related to growth hormone-releasing hormone (GHRH). Sermorelin acts on the pituitary to stimulate the release of growth hormone.
Use Sermorelin exactly as prescribed by your healthcare provider and follow the administration instructions supplied with your medication. Do not change the dose or frequency without provider guidance.
Treatment with sermorelin may cause local injection-site reactions or other adverse effects. Your provider should review your medical history, medications, allergies, and individual risk factors before treatment.
Your healthcare provider determines whether sermorelin is appropriate for you and explains the expected use, administration, monitoring, and potential risks of your prescribed formulation.
Start Your Sermorelin
Care Journey
A simple, provider-guided process to determine whether sermorelin treatment may be appropriate for your individual needs.
- 1Get Started
Provide the information needed for a licensed healthcare provider to understand your health and treatment needs.
Start online
- 2Provider Review
A licensed healthcare provider reviews your information and determines whether sermorelin may be clinically appropriate for you.
Prescription required
- 3Start Your Treatment
If prescribed, receive your medication and follow the administration and treatment instructions provided by your healthcare provider.
Provider-guided care
Important Things to Know
Before Starting Treatment
Review important considerations about sermorelin, administration, health factors, treatment monitoring, and provider-guided care.
- Understanding Sermorelin and GHRH
- Using Your Prescribed Treatment
- Administration and Injection Guidance
- Health Conditions and Medications
- Potential Side Effects and Reactions
- Monitoring Your Treatment
Sermorelin treatment requires evaluation and a prescription from a licensed healthcare provider. Treatment suitability, formulation, dosage, administration, and ongoing monitoring vary by patient.
Explore More
Treatment Options
Explore other wellness and peptide treatment options available through provider-guided care and review which approach may be appropriate for your needs.
NAD+ 300mg/mL Nasal Spray
Starts atFrom $99/moPrescription requiredSermorelin 3mg/mL (5mL) (you’re viewing this)
Starts atFrom $99/moPrescription requiredSermorelin 3mg/mL (5mL)
Starts atFrom $99/moPrescription requiredLIPO-B (MIC + B12) 25/50/50/1 mg/mL (10mL)
Starts atFrom $99/moPrescription requiredNAD+ 100mg/mL (10mL Vial)
Starts atFrom $99/moPrescription required
Your Sermorelin
Care Plan
Your provider determines the appropriate treatment approach and may review your response and treatment experience over time.
If prescribed, your provider will explain how to use the nasal spray and review important treatment considerations.
Use the nasal spray according to your prescription and the administration instructions supplied with your medication.
Your provider may review your response, tolerance, and ongoing treatment needs to determine the appropriate next step.
Treatment plans, dosage, administration instructions, and monitoring vary by patient. Do not change your treatment without discussing it with your healthcare provider.
Frequently Asked Questions
Sermorelin is a synthetic peptide related to growth hormone-releasing hormone (GHRH). It acts on the pituitary to stimulate growth hormone release. Your provider determines whether the specific 3mg/mL formulation is appropriate for you.
Sermorelin stimulates the pituitary to release growth hormone. Historically, FDA approved sermorelin acetate under the brand Geref for a specific pediatric growth-hormone-deficiency indication. That historical approval does not establish approval of the current compounded 3mg/mL product or other wellness uses.
FDA records show that sermorelin acetate was historically approved as Geref for treatment of idiopathic or organic growth hormone deficiency in children with growth failure. However, the current 3mg/mL compounded formulation should not be described as FDA-approved unless its exact product has an applicable FDA approval. Compounded drugs themselves are not FDA-approved.
Use sermorelin exactly as prescribed and follow the administration instructions supplied with your medication. Because compounded formulations and concentrations can differ, do not use instructions from another sermorelin product.
Potential adverse effects can include injection-site reactions and other treatment-related effects. Your healthcare provider should review the potential risks and your individual health circumstances before treatment.
Sermorelin is a prescription peptide treatment. The exact formulation, indication, dosage, administration instructions, and monitoring plan should be determined by a licensed healthcare provider and confirmed against the dispensing pharmacy's product information.